Biogen Inc. Common Stock (BIIB) Financials
Key financial figures for Biogen Inc. Common Stock (Q2 2026).
- Revenue
- $2.7B
- Net Income
- $98M
- EPS
- $0.66
- Total Assets
- $32.1B
- Operating Cash Flow
- $449M
Full income statement, balance sheet, and cash flow for Biogen Inc. Common Stock on SentiSense.